Advisory Services Network’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $347K | Buy |
+1,836
| New | +$321K | ﹤0.01% | 1490 |
|
|
2025
Q4 | – | Sell |
-30
| Closed | -$3.95K | – | 3099 |
|
|
2025
Q3 | $3.95K | Buy |
+30
| New | +$3.6K | ﹤0.01% | 3611 |
|
|
2024
Q1 | – | Sell |
-38
| Closed | -$4.67K | – | 2583 |
|
|
2023
Q4 | $4.67K | Buy |
+38
| New | +$4.74K | ﹤0.01% | 3133 |
|
|
2023
Q2 | – | Sell |
-43
| Closed | -$6.29K | – | 2559 |
|
|
2023
Q1 | $6.29K | Hold |
43
| – | – | ﹤0.01% | 3065 |
|
|
2022
Q4 | $6.85K | Buy |
+43
| New | +$6.3K | ﹤0.01% | 3016 |
|
|
2021
Q4 | – | Sell |
-4,208
| Closed | -$548K | – | 1455 |
|
|
2021
Q3 | $548K | Buy |
4,208
+4,002
| +1,943% | +$605K | 0.02% | 834 |
|
|
2021
Q2 | $37K | Buy |
+206
| New | +$35.7K | ﹤0.01% | 2150 |
|
|
2021
Q1 | – | Sell |
-213
| Closed | -$35K | – | 2167 |
|
|
2020
Q4 | $35K | Sell |
213
-107
| -33% | -$15.9K | ﹤0.01% | 1857 |
|
|
2020
Q3 | $47K | Buy |
+320
| New | +$39.7K | ﹤0.01% | 1622 |
|
|
2020
Q2 | – | Sell |
-286
| Closed | -$28K | – | 1922 |
|
|
2020
Q1 | $28K | Buy |
286
+220
| +333% | +$28.4K | ﹤0.01% | 1673 |
|
|
2019
Q4 | $10K | Sell |
66
-68
| -51% | -$9.25K | ﹤0.01% | 2349 |
|
|
2019
Q3 | $19K | Hold |
134
| – | – | ﹤0.01% | 1850 |
|
|
2019
Q2 | $19K | Hold |
134
| – | – | ﹤0.01% | 1848 |
|
|
2019
Q1 | $19K | Buy |
134
+7
| +6% | +$913 | ﹤0.01% | 1634 |
|
|
2018
Q4 | $16K | Sell |
127
-2,448
| -95% | -$363K | ﹤0.01% | 1580 |
|
|
2018
Q3 | $433K | Buy |
2,575
+2,550
| +10,200% | +$439K | 0.03% | 555 |
|
|
2018
Q2 | $4K | Hold |
25
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q1 | $4K | Sell |
25
-175
| -88% | -$25.7K | ﹤0.01% | 2208 |
|
|
2017
Q4 | $27K | Sell |
200
-225
| -53% | -$31.2K | ﹤0.01% | 1510 |
|
|
2017
Q3 | $62K | Buy |
425
+75
| +21% | +$11.3K | 0.01% | 1022 |
|
|
2017
Q2 | $54K | Hold |
350
| – | – | 0.01% | 1024 |
|
|
2017
Q1 | $51K | Buy |
+350
| New | +$45.6K | 0.01% | 992 |
|
|
2016
Q3 | $43K | Hold |
350
| – | – | 0.01% | 909 |
|
|
2016
Q2 | $49K | Hold |
350
| – | – | 0.01% | 793 |
|
|
2016
Q1 | $46K | Buy |
+350
| New | +$43.6K | 0.01% | 688 |
|
|
2015
Q3 | – | Sell |
-4
| Closed | -$1K | – | 1552 |
|
|
2015
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1340 |
|
|
2015
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 1243 |
|
|
2014
Q4 | $1K | Buy |
+4
| New | +$664 | ﹤0.01% | 1160 |
|
Other funds holding JAZZ
VPM
VCM
EC
Advisory Services Network's JAZZ Position: Q1 2026 in Review
Advisory Services Network opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 1,836 shares worth $347K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in JAZZ as recently as Q3 2025.
Advisory Services Network first reported a position in JAZZ in Q4 2014 and has held it in 28 quarters since. The position peaked at $548K in Q3 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Advisory Services Network held 1,836 shares of Jazz Pharmaceuticals worth $347K as of Q1 2026.
- Jazz Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #1490 holding.
- Advisory Services Network first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 28 quarters since.
- Advisory Services Network's Jazz Pharmaceuticals position peaked at $548K in Q3 2021.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.